Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Belina Pharma AB
AB
Active
Org 5591111892
Markörvägen 16, 226 49
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2017 · 9 years old
0 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Belina Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
-1M
-100%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
—
—
Staff expenses
—
—
—
—
—
EBITDA
−345
−111
−116
−343
−530
Depreciation & amort.
−0
−6
−20
−20
−20
EBIT
−345
−117
−136
−363
−549
Net financials
—
—
—
−1
−0
Profit before tax
−345
−117
−136
—
—
Tax
−0
−0
−0
—
—
Net profit
−345
−117
−136
−364
−550
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
544
1 317
1 136
898
415
Equity
35
518
381
417
268
Long-term debt
0
0
0
—
—
Short-term debt
509
800
754
481
148
Total debt
509
800
754
481
148
Financial ratios
5-year trend
EBITDA-margin
-52957500.0%
This company
15.8%
Market median
-335174151% vs market
2020
2024
Soliditetsgrad
64.5%
This company
38.2%
Market median
+69% vs market
2020
2024
Egenkapitalforrentning
-205.3%
This company
18.4%
Market median
-1216% vs market
2020
2024
Nettoresultatgrad
-54966800.0%
This company
8.1%
Market median
-678602569% vs market
2020
2024
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Gæld/egenkapital
0.55×
This company
0.62×
Market median
+11% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Belina Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
